Acumen Pharmaceuticals Stock Market Value
| ABOS Stock | USD 2.63 0.00 0.00% |
| Symbol | Acumen |
Is there potential for Biotechnology market expansion? Will Acumen introduce new products? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Acumen Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Acumen Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Acumen Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Acumen Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Acumen Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Acumen Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Acumen Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acumen Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acumen Pharmaceuticals.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Acumen Pharmaceuticals on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Acumen Pharmaceuticals or generate 0.0% return on investment in Acumen Pharmaceuticals over 90 days. Acumen Pharmaceuticals is related to or competes with Inovio Pharmaceuticals, Opus Genetics, Agenus, Alector, Seer, Seres Therapeutics, and Fate Therapeutics. Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treat... More
Acumen Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acumen Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acumen Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.71 | |||
| Information Ratio | 0.0622 | |||
| Maximum Drawdown | 31.48 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 9.94 |
Acumen Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acumen Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acumen Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Acumen Pharmaceuticals historical prices to predict the future Acumen Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0591 | |||
| Jensen Alpha | 0.3828 | |||
| Total Risk Alpha | 0.1206 | |||
| Sortino Ratio | 0.0815 | |||
| Treynor Ratio | 0.407 |
Acumen Pharmaceuticals February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0591 | |||
| Market Risk Adjusted Performance | 0.417 | |||
| Mean Deviation | 4.21 | |||
| Semi Deviation | 4.52 | |||
| Downside Deviation | 4.71 | |||
| Coefficient Of Variation | 1439.29 | |||
| Standard Deviation | 6.17 | |||
| Variance | 38.07 | |||
| Information Ratio | 0.0622 | |||
| Jensen Alpha | 0.3828 | |||
| Total Risk Alpha | 0.1206 | |||
| Sortino Ratio | 0.0815 | |||
| Treynor Ratio | 0.407 | |||
| Maximum Drawdown | 31.48 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 9.94 | |||
| Downside Variance | 22.2 | |||
| Semi Variance | 20.45 | |||
| Expected Short fall | (4.91) | |||
| Skewness | 1.92 | |||
| Kurtosis | 8.06 |
Acumen Pharmaceuticals Backtested Returns
Acumen Pharmaceuticals appears to be very risky, given 3 months investment horizon. Acumen Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. By analyzing Acumen Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please makes use of Acumen Pharmaceuticals' Mean Deviation of 4.21, risk adjusted performance of 0.0591, and Downside Deviation of 4.71 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Acumen Pharmaceuticals holds a performance score of 8. The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. Acumen Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Acumen Pharmaceuticals is expected to follow. Please check Acumen Pharmaceuticals' value at risk, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Acumen Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.52 |
Modest predictability
Acumen Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Acumen Pharmaceuticals time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acumen Pharmaceuticals price movement. The serial correlation of 0.52 indicates that about 52.0% of current Acumen Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.